79 related articles for article (PubMed ID: 9581873)
21. Reduction in transforming growth factor beta receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid.
Chang DJ; Ji C; Kim KK; Casinghino S; McCarthy TL; Centrella M
J Biol Chem; 1998 Feb; 273(9):4892-6. PubMed ID: 9478931
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional and post-transcriptional regulation of transforming growth factor beta type II receptor expression in osteoblasts.
Chang W; Parra M; Ji C; Liu Y; Eickelberg O; McCarthy TL; Centrella M
Gene; 2002 Oct; 299(1-2):65-77. PubMed ID: 12459253
[TBL] [Abstract][Full Text] [Related]
23. runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins.
Javed A; Barnes GL; Jasanya BO; Stein JL; Gerstenfeld L; Lian JB; Stein GS
Mol Cell Biol; 2001 Apr; 21(8):2891-905. PubMed ID: 11283267
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype.
Banerjee C; Javed A; Choi JY; Green J; Rosen V; van Wijnen AJ; Stein JL; Lian JB; Stein GS
Endocrinology; 2001 Sep; 142(9):4026-39. PubMed ID: 11517182
[TBL] [Abstract][Full Text] [Related]
25. Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts.
Prince M; Banerjee C; Javed A; Green J; Lian JB; Stein GS; Bodine PV; Komm BS
J Cell Biochem; 2001; 80(3):424-40. PubMed ID: 11135373
[TBL] [Abstract][Full Text] [Related]
26. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation.
Alliston T; Choy L; Ducy P; Karsenty G; Derynck R
EMBO J; 2001 May; 20(9):2254-72. PubMed ID: 11331591
[TBL] [Abstract][Full Text] [Related]
27. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors.
Lian JB; Javed A; Zaidi SK; Lengner C; Montecino M; van Wijnen AJ; Stein JL; Stein GS
Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):1-41. PubMed ID: 15104525
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E2 increases transforming growth factor-beta type III receptor expression through CCAAT enhancer-binding protein delta in osteoblasts.
McCarthy TL; Pham TH; Knoll BI; Centrella M
Mol Endocrinol; 2007 Nov; 21(11):2713-24. PubMed ID: 17636036
[TBL] [Abstract][Full Text] [Related]
29. A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element.
Geoffroy V; Ducy P; Karsenty G
J Biol Chem; 1995 Dec; 270(52):30973-9. PubMed ID: 8537354
[TBL] [Abstract][Full Text] [Related]
30. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes.
Kern B; Shen J; Starbuck M; Karsenty G
J Biol Chem; 2001 Mar; 276(10):7101-7. PubMed ID: 11106645
[TBL] [Abstract][Full Text] [Related]
31. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex.
Banerjee C; McCabe LR; Choi JY; Hiebert SW; Stein JL; Stein GS; Lian JB
J Cell Biochem; 1997 Jul; 66(1):1-8. PubMed ID: 9215522
[TBL] [Abstract][Full Text] [Related]
32. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.
Ducy P; Zhang R; Geoffroy V; Ridall AL; Karsenty G
Cell; 1997 May; 89(5):747-54. PubMed ID: 9182762
[TBL] [Abstract][Full Text] [Related]
33. Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype.
Centrella M; Casinghino S; Kim J; Pham T; Rosen V; Wozney J; McCarthy TL
Mol Cell Biol; 1995 Jun; 15(6):3273-81. PubMed ID: 7760823
[TBL] [Abstract][Full Text] [Related]
34. Cloning the promoter for transforming growth factor-beta type III receptor. Basal and conditional expression in fetal rat osteoblasts.
Ji C; Chen Y; McCarthy TL; Centrella M
J Biol Chem; 1999 Oct; 274(43):30487-94. PubMed ID: 10521429
[TBL] [Abstract][Full Text] [Related]
35. Cbfa1 isoforms exert functional differences in osteoblast differentiation.
Harada H; Tagashira S; Fujiwara M; Ogawa S; Katsumata T; Yamaguchi A; Komori T; Nakatsuka M
J Biol Chem; 1999 Mar; 274(11):6972-8. PubMed ID: 10066751
[TBL] [Abstract][Full Text] [Related]
36. Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization.
Javed A; Gutierrez S; Montecino M; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Mol Cell Biol; 1999 Nov; 19(11):7491-500. PubMed ID: 10523637
[TBL] [Abstract][Full Text] [Related]
37. Characterization of an osteoblast-specific enhancer element in the CBFA1 gene.
Zambotti A; Makhluf H; Shen J; Ducy P
J Biol Chem; 2002 Nov; 277(44):41497-506. PubMed ID: 12186862
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Osf1, an osteoblast-specific transcription factor binding to a critical cis-acting element in the mouse Osteocalcin promoters.
Schinke T; Karsenty G
J Biol Chem; 1999 Oct; 274(42):30182-9. PubMed ID: 10514508
[TBL] [Abstract][Full Text] [Related]
39. Study of osteoblast-specific expression of one mouse osteocalcin gene: characterization of the factor binding to OSE2.
Ducy P; Geoffroy V; Karsenty G
Connect Tissue Res; 1996; 35(1-4):7-14. PubMed ID: 9084638
[TBL] [Abstract][Full Text] [Related]
40. PTH-responsive osteoblast nuclear matrix architectural transcription factor binds to the rat type I collagen promoter.
Alvarez M; Thunyakitpisal P; Morrison P; Onyia J; Hock J; Bidwell JP
J Cell Biochem; 1998 Jun; 69(3):336-52. PubMed ID: 9581872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
